# SAB Biotherapeutics, Inc.: Form DEF 14A, filed Jun 2, 2025

- Company: [SAB Biotherapeutics, Inc.](/companies/sabs.md) (CIK 1833214)
- Form: DEF 14A
- Filed: 2025-06-02
- Accepted by EDGAR: Jun 2, 2025, 21:00 ET
- Period: 2025-07-17
- Accession: 0000950170-25-080361
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1833214/000095017025080361/sabs_def14a_fy25agm.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1833214/000095017025080361/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1833214/000095017025080361/sabs_def14a_fy25agm.htm

Filed Jun 2, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-080361. Last ingested by Listed: Oct 24, 2026, 14:57 ET. No prices; not investment advice.